Toward this aim, we evaluated the utility of FLNA alone without other risk factors in both CA men and AA men separately and found that FLNA provides superior performance in distinguishing men with BPH from men with PCa as compared to PSA in both patient groups. Here, KLK3 is linked to benign prostatic hyperplasia.